HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.5 EUR 2.04% Market Closed

Market Cap: €117m

	Heidelberg Pharma AG XETRA:HPHA	DE
	Core & Main Inc NYSE:CNM	US
B	Boston Scientific Corp DUS:BSX	US

Profitability Summary

Heidelberg Pharma AG's profitability score is 10/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

73% > 87%

Negative Operating Margin

-432%

Negative 3Y Average Operating Margin

-670%

Declining Operating Margin

-238% > -432%

Negative Net Margin

-445%

Negative 3Y Average Net Margin

-635%

Declining Net Margin

-236% > -445%

Negative Free Cash Flow Margin

-334%

Negative 3Y Average Free Cash Flow Margin

-648%

Free Cash Flow Margin is Increasing

-374% > -334%

Negative ROE

-1.540%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-124%

Declining ROIC

-133% > -162%

View All

Hide

Collapse

10 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.